Jo J - Search Results

1

Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.

Filella X, Molina R, Jo J, Bedini JL, Joseph J, Ballesta AM. Filella X, et al. Among authors: jo j. Bull Cancer. 1992;79(3):271-7. Bull Cancer. 1992. PMID: 1392166 Review.

2

A prospective study of tumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas.

Molina R, Ojeda B, Filella X, Borras G, Jo J, Mas E, Lopez JJ, Ballesta A. Molina R, et al. Among authors: jo j. Tumour Biol. 1992;13(5-6):278-86. doi: 10.1159/000217776. Tumour Biol. 1992. PMID: 1290025

3

Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.

Filella X, Molina R, Jo J, Umbert B, Bedini JL, Ballesta AM. Filella X, et al. Among authors: jo j. Tumour Biol. 1990;11(6):289-94. doi: 10.1159/000217664. Tumour Biol. 1990. PMID: 1700860

4

Tumor markers in patients with chronic renal failure.

Filella X, Cases A, Molina R, Jo J, Bedini JL, Revert L, Ballesta AM. Filella X, et al. Among authors: jo j. Int J Biol Markers. 1990 Apr-Jun;5(2):85-8. Int J Biol Markers. 1990. PMID: 1704405

5

Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.

Filella X, Molina R, Mengual PJ, Jo J, Ballesta AM. Filella X, et al. Among authors: jo j. J Nucl Biol Med (1991). 1991 Jul-Sep;35(3):158-61. J Nucl Biol Med (1991). 1991. PMID: 1816871

6

CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels.

Molina R, Agusti C, Mañe JM, Filella X, Jo J, Joseph J, Giménez N, Estapé J, Ballesta AM. Molina R, et al. Among authors: jo j. Int J Biol Markers. 1994 Apr-Jun;9(2):96-101. doi: 10.1177/172460089400900206. Int J Biol Markers. 1994. PMID: 7523548 Clinical Trial.

7

Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.

Molina R, Torres MD, Moragas M, Filella X, Jo J, Giménez N, Traserra J, Ballesta AM. Molina R, et al. Among authors: jo j. Anticancer Res. 1995 Mar-Apr;15(2):479-84. Anticancer Res. 1995. PMID: 7763026

8

Carcinoembryonic antigen in staging and follow-up of patients with solid tumors.

Ballesta AM, Molina R, Filella X, Jo J, Giménez N. Ballesta AM, et al. Among authors: jo j. Tumour Biol. 1995;16(1):32-41. doi: 10.1159/000217926. Tumour Biol. 1995. PMID: 7863220 Review.

9

Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases.

Molina R, Agusti C, Filella X, Jo J, Joseph J, Giménez N, Ballesta AM. Molina R, et al. Among authors: jo j. Tumour Biol. 1994;15(6):318-25. doi: 10.1159/000217908. Tumour Biol. 1994. PMID: 7997803

10

Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.

Molina R, Jo J, Filella X, Zanon G, Grau JJ, Joseph J, Bedini JL, Biete A, Ballesta AM. Molina R, et al. Among authors: jo j. Int J Biol Markers. 1993 Apr-Jun;8(2):113-23. doi: 10.1177/172460089300800208. Int J Biol Markers. 1993. PMID: 8366294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,047 results

Search Page

Filters